S

E

SCHIAROLI , E.

Last name: SCHIAROLI

First name: E.

2017 (v1)

Publication

Metadata-only

Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Di Giambenedetto, S. Fabbiani, M. Quiros Roldan, E.

Background: Combination ART (cART)-related toxicities and costs have prompted the need for treatment simplification. The ATLAS-M trial explored 48 week non-inferior efficacy of simplification to atazanavir/ritonavir + lamivudine versus maintaining three-drug atazanavir/ritonavir-based cART in virologically suppressed patients. Methods: We...

Uploaded on: April 14, 2023
2021 (v1)

Publication

Metadata-only

SELP Asp603Asn and severe thrombosis in COVID-19 males: Implication for anti P-selectin monoclonal antibodies treatment

Fallerini, C. Daga, S. Benetti, E.

No description

Uploaded on: September 24, 2024